Insider Trading & Ownership - Venkatesan Jay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Venkatesan Jay
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-02-09
Sale(A)		2022-05-27
4:20 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		159,177$16$2,546,8321,439,525
(Direct)		View
2022-05-25
Purchase		2022-05-27
4:18 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		11,313$1.2466$14,1031,891,947
(Direct)		View
2022-05-20
Purchase		2022-05-25
5:58 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		82,200$1.2339$101,4281,721,457
(Direct)		View
2021-12-27
Purchase		2021-12-29
4:08 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		277,244$2.6344$730,3731,639,257
(Direct)		View
2021-12-20
Purchase		2021-12-22
4:06 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		3,527$2.5449$8,9761,362,013
(Direct)		View
2021-12-16
Purchase		2021-12-20
6:44 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		41,625$2.5454$105,9511,358,486
(Direct)		View
2021-12-15
Purchase		2021-12-17
5:13 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		77,604$2.4091$186,9561,316,861
(Direct)		View
2021-09-17
Sale		2021-09-21
5:14 pm		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		400,000$9.4$3,760,0002,856,309
(Indirect
Direct)		View
2021-02-09
Sale		2021-02-11
7:25 pm		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		159,177$16$2,546,8321,280,348
(Direct)		View
2019-08-02
Purchase		2019-08-06
5:11 pm		EXICURE INC.XCURVenkatesan Jay
Director		250,000$2$500,000650,049
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-12-28
Option Award		2023-12-29
5:05 pm		N/A
2033-12-28		Elicio Therapeutics Inc.ELTXVenkatesan Jay
Director		4,100$04,100
(Direct)		View
2022-07-15
Exercise		2022-07-19
4:38 pm		N/A
2025-12-15		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		20,063$0.452,946,372
(Direct)		View
2021-02-09
Exercise(A)		2022-05-27
4:20 pm		N/A
2028-07-05		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		396,329$01,439,525
(Direct)		View
2021-02-09
Exercise(A)		2022-05-27
4:20 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		396,329$6.431,439,525
(Direct)		View
2021-02-09
Conversion(A)		2022-05-27
4:20 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		262$11.571,439,525
(Direct)		View
2022-03-03
Option Award		2022-03-04
4:22 pm		N/A
2032-03-02		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		760,000$01,360,000
(Direct)		View
2022-01-03
Option Award		2022-01-04
5:37 pm		N/A
2032-01-02		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		10,000$010,000
(Direct)		View
2021-06-24
Tax Withholding		2021-12-17
5:13 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		41,091$13.781,316,861
(Direct)		View
2021-03-30
Exercise		2021-04-23
6:14 pm		N/A
N/A		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		7,650$4.093,256,309
(Direct)		View
2021-03-30
Exercise		2021-04-23
6:14 pm		N/A
2029-01-01		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		15,300$03,256,309
(Direct)		View
2021-03-31
Exercise		2021-04-23
6:14 pm		N/A
N/A		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		7,650$3.62333,256,309
(Direct)		View
2021-02-09
Exercise		2021-02-11
7:25 pm		N/A
2028-07-05		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		237,152$01,280,348
(Direct)		View
2021-02-09
Exercise		2021-02-11
7:25 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		237,152$6.431,280,348
(Direct)		View
2021-02-09
Conversion		2021-02-11
7:25 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		170,037$01,280,348
(Direct)		View
2021-02-09
Conversion		2021-02-11
7:25 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		262$11.571,280,348
(Direct)		View
2021-02-09
Tax Withholding		2021-02-11
7:25 pm		N/A
N/A		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		31,966$161,280,348
(Direct)		View
2021-02-04
Option Award		2021-02-08
12:57 pm		N/A
2031-02-03		Angion Biomedica Corp.ANGNVenkatesan Jay
See Remarks		178,920$0178,920
(Direct)		View

Ownership		2021-02-04
5:31 pm		N/A
N/A		Angion Biomedica Corp.ANGVenkatesan Jay
See Remarks		0$02,638,158
(Direct)		View
2021-01-04
Option Award		2021-01-05
7:03 pm		N/A
2031-01-03		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		7,650$07,650
(Direct)		View
2020-12-22
Other		2020-12-22
5:30 pm		N/A
N/A		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		1,174,825$04,415,834
(Indirect)		View
2020-07-06
Exercise		2020-07-08
4:46 pm		N/A
N/A		EXICURE INC.XCURVenkatesan Jay
Director		12,930$1.03672,288
(Direct)		View
2020-07-06
Exercise		2020-07-08
4:46 pm		N/A
2024-02-17		EXICURE INC.XCURVenkatesan Jay
Director		22,240$0672,288
(Direct)		View
2020-07-06
Exercise		2020-07-08
4:46 pm		N/A
N/A		EXICURE INC.XCURVenkatesan Jay
Director		9,310$0.65672,288
(Direct)		View
2020-06-04
Option Award		2020-06-08
7:22 pm		N/A
2030-06-03		EXICURE INC.XCURVenkatesan Jay
Director		21,693$021,693
(Direct)		View
2020-01-02
Option Award		2020-01-06
8:02 pm		N/A
2030-01-01		ALPINE IMMUNE SCIENCES INC.ALPNVenkatesan Jay
Director
10% Owner		7,650$07,650
(Direct)		View
2019-06-14
Option Award		2019-06-14
5:37 pm		N/A
2029-06-13		EXICURE INC.XCURVenkatesan Jay
Director		21,693$021,693
(Direct)		View
(A) Indicate amendment filing.